Sepsis-induced Coagulopathy
📧 Sign up to get email alerts when something new happens for Sepsis-induced Coagulopathy.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: A Study to Learn About How Safe BAY 3389934 is, Its Suitable Dose, and How it Affects the Participants With Sepsis Induced Coagulopathy [Phase 1]
A Phase 1 clinical trial assessing safety, dosing, and pharmacodynamic effects of BAY 3389934 in participants with sepsis-induced coagulopat…
-
CLINICAL_TRIALS research · 2025-05-29Clinical Trial Update: The Impact of Nafamostat Mesylate on the Prognosis of Patients With Sepsis-Induced Coagulopathy Undergoing Hemofiltration [NA]
This entry notes a trial evaluating nafamostat mesylate for prognosis in sepsis-induced coagulopathy patients undergoing hemofiltration, wit…
-
CLINICAL_TRIALS trial_result · 2023-10-12Clinical Trial Update: Nafamostat Mesilate in the Treatment of Severe Infection-associated Coagulopathy [Phase 4]
Phase 4 clinical trial update evaluating Nafamostat Mesilate for severe infection-associated coagulopathy related to sepsis and sepsis-induc…